Wed, Jul 30, 2014, 3:33 PM EDT - U.S. Markets close in 27 mins.

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

  • bohemianclubman bohemianclubman Feb 26, 2014 10:08 AM Flag

    By the way...

     

    This paragraph, posted by kinkey boots a.k.a. terry the clown:This may be the delay :
    Unless we see cures in the Ph2/3, we think immediate US filing is
    unlikely, no matter what KOLs agitate FDA for. Based on our KOL
    conversations, we think FDA still has a lot to learn about NTM, having
    been previously hung up on TB-like “cure” endpoints. Given trial patients
    are end of the line, hard to treat, cures with only 3-mo Tx are unlikely.
    INSM may decide to focus initial registration on a subset of patients
    based on pre-specified stratification (CF; organism) depending on data.

    Comes from a source known as Stock Market Magic, The Apprentice Millionaire. You can join this elite service for the price of $1.00 per month, or you can simply log on to Amazon and purchase the book!! The book has a stunning five star review based on......one review!! And here we have Terry the Clown quoting as if this is fact and indeed the "problem" that will lead to a delay.....he continues to be way more fos than any outhouse....

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
INSM
17.58+0.08(+0.46%)3:33 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.